ArticleFrontiers in medicine2020
The Lebanese COVID-19 Cohort; A Challenge for the ABO Blood Group System.
Article in Frontiers in medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.
- Systematic review and meta-analysis of the effect of ABO blood group on the risk of SARS-CoV-2 infection.PloS one · 2022Pooled it
- Association of ABO/Rh Blood Groups and ABO Gene VariantsViruses · 2026Article
- A retrospective study on the association between ABO blood group and the severity and prognosis of hospitalized Chinese patients with COVID-19.BMC infectious diseases · 2025Article
- ABO Blood Groups and Incidence of COVID-19 in the Mass Gathering Events in Borriana (Spain), March 2020: A Retrospective Cohort Study.Epidemiologia (Basel, Switzerland) · 2023Article
- ABO blood group and link to COVID-19: A comprehensive review of the reported associations and their possible underlying mechanisms.Microbial pathogenesis · 2022Review
- COVID-19 outbreak in a psychiatric hospital: what makes it worse?Annals of general psychiatry · 2022Article
- Article
- ABO blood type analysis of the donors of convalescent plasma after COVID-19 infection in Chelyabinsk region, Russia.Vox sanguinis · 2022Article
- Impact of ABO and Rhesus blood groups on COVID-19 susceptibility and severity: A case-control study.Journal of medical virology · 2022Article
- Article
- Effects of ABO blood groups and RH-factor on COVID-19 transmission, course and outcome: A review.Frontiers in medicine · 2022Review
- The relationship between blood groups and risk of infection with SARS-CoV-2 or development of severe outcomes: A review.Reviews in medical virology · 2022Review
- Association of ABO blood group with susceptibility to SARS-CoV-2 infection in Rupandehi district of Nepal.SAGE open medicine · 2022Article
- SARS-CoV-2 Infection Susceptibility of Pregnant Patients at Term Regarding ABO and Rh Blood Groups: A Cohort Study.Medicina (Kaunas, Lithuania) · 2021Article
- Challenge of forecasting demand of medical resources and supplies during a pandemic: A comparative evaluation of three surge calculators for COVID-19.Epidemiology and infection · 2021Article
- Questioning the sex-specific differences in the association of smoking on the survival rate of hospitalized COVID-19 patients.PloS one · 2021Article
- Allelic Variants Within the ABO Blood Group Phenotype Confer Protection Against Critical COVID-19 Hospital Presentation.Frontiers in medicine · 2021Article
- Inverse Association Between the Mediterranean Diet and COVID-19 Risk in Lebanon: A Case-Control Study.Frontiers in nutrition · 2021Article
- Correlation between ABO blood type, susceptibility to SARS-CoV-2 infection and COVID-19 disease severity: A systematic review.Hematology, transfusion and cell therapyReview
- ABO blood group association and COVID-19. COVID-19 susceptibility and severity: a review.Hematology, transfusion and cell therapyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A sudden outbreak of pneumonia caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has rapidly spread all over the world facilitating the declaration of the resultant disease as a pandemic on March 2020. Predisposing factors for acquiring COVID-19 and for developing a severe form of this disease were postulated to be related to the epidemiological, clinical, and genetic characteristics of the patients. Biological markers such as the ABO blood group system were amongst these factors that were proposed to be linked to the variability in the disease course and/or the prevalence of the infection among different groups. Herein, we conducted the first retrospective case-control study from the Middle East and North Africa that tackles the association between the blood group types and the susceptibility to, as well as the severity of, SARS-CoV-2 infection. Contrary to the most acknowledged hypothesis, our results challenged the significance of this association and questioned the role of the ABO blood group system in dictating the severity of this disease. For future similar studies, we endorsed analyzing larger cohorts among different populations and we encouraged implementing more rigorous approaches to diminish the potential confounding effect of some underlying comorbidities and genetic variants that are known to be associated with the ABO blood group system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.